Purchase Order HT001416P0423
- Not listed
- This federal contract award, with a value of $11,427.90, was issued by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract is for the procurement of prosthetic order stents, a type of medical device, with a performance period ending on December 31, 2024. This is a firm-fixed-price purchase order, and the contract does not have a set-aside designation, indicating that Bard competed for the award based on its capabilities...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The $11,001.00 contract is for the delivery of STENTS and has an ultimate completion date of October 16, 2024. Bard is a manufacturer of medical devices, including vascular stents, surgical implants, catheters, and other specialized equipment used in healthcare settings. The contract was awarded through the...
- This federal contract award was issued by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network (VISN) 7, to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company (BD). The $17,400.00 firm-fixed-price purchase order is for the delivery of medical devices and supplies, including vascular stents, surgical implants, catheters, and temperature management systems, to support VA healthcare facilities. The contract has an ultimate completion date of...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to C.R. Bard, Inc., a subsidiary of Becton, Dickinson and Company, for the supply of vascular stents. The single-award contract has a potential value of $11,250.00 and a completion date of September 30, 2024. C.R. Bard, Inc. is a for-profit medical technology company that provides a wide range of medical devices and supplies to federal agencies, including the Department of Veterans...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,891.00, is for the delivery of three (3) vascular stents to support the VA's healthcare operations. The contract has an ultimate completion date of December 31, 2024 and does not utilize any set-aside designations. Bard is a manufacturer of a wide range of medical devices and...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company (BD). The contract, valued at $14,660.80, is for the delivery of three vascular stents to be used in the VA's healthcare facilities. The contract has an ultimate completion date of March 31, 2025 and was awarded on December 3, 2024. Bard is a for-profit medical device manufacturer that has a long-standing...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 15 (VISN 15), to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD). The contract is for the delivery of two vascular stents, with a ceiling value of $10,162.79 and a period of performance ending on March 31, 2025. The contract does not have a set-aside designation, indicating that Bard competed for the...
- This federal contract award is for the purchase of VASCULAR STENTS by the Department of Veterans Affairs (VA), specifically through Veterans Integrated Service Network (VISN) 15. The contract was awarded to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company (BD), a global medical technology manufacturer. The contract has a ceiling value of $10,089.89 and is a firm-fixed-price purchase order with a completion date of June 30, 2025. The contract does not...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to C.R. Bard, Inc. (doing business as Bard), a subsidiary of Becton, Dickinson and Company. The contract, valued at $12,702.80, is for the delivery of three vascular stents to support the agency's medical supply requirements. The purchase order does not have a set-aside designation, indicating that Bard competed for the award based on its capabilities as a...
- This federal contract award is for the delivery of 7mm ID x 100mm long Nitinol Bard vascular stents to the Food and Drug Administration (FDA). The $27,280.00 firm fixed price purchase order was awarded to C R Bard Inc., a subsidiary of Becton, Dickinson and Company (BD), a global medical technology company. The stents are needed to quantify disturbed flow in an in vitro flow model of a superficial femoral artery (SFA) curved Bard peripheral vascular device. The award is not associated with a...
This federal contract award, valued at $3,233.30, was issued by the Defense Health Agency to C R Bard Inc., a subsidiary of Becton, Dickinson and Company (BD). The contract is for the purchase of 788628 INLAY OPTIMA STENT 6 X 28 medical devices. This is a firm fixed-price purchase order that does not have a set-aside designation. C R Bard Inc. is a manufacturer of a wide range of medical devices and supplies, including catheters, surgical mesh, stents, and temperature management systems. The company has an extensive history of providing medical equipment and disposables to various federal agencies, particularly the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. This contract award demonstrates C R Bard's continued role as a key vendor in the government medical supply chain, supplying essential urological products to support patient care in VA medical centers, Bureau of Prisons sites, Indian Health Service locations, and Federal Health Care Centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/13/16 |